Skip to content

Clinical trials

Scleroderma, Systemic trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: South Korea Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20151
20162
20172
20181
20201
20222
20232
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Unknown status3
Terminated2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital5
Boehringer Ingelheim2
Amgen1
AstraZeneca1
GlaxoSmithKline1
Kite, A Gilead Company1
Pfizer1
Prolium Bioscience, Inc1
Suk-Ho Moon1
The Catholic University of Korea1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic15
Scleroderma, Diffuse5
Lung Diseases, Interstitial2
Raynaud Disease2
Autoimmune Diseases1
Gangrene1
Immune System Diseases1
Lupus Erythematosus, Systemic1
Lupus Nephritis1
Myositis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.